Key Ruling Foils GSK Zofran MDL Ahead Of Bellwether
GlaxoSmithKline will not have to face more than 420 suits in multidistrict litigation alleging its anti-nausea medication Zofran causes birth defects after a Massachusetts federal judge ruled Tuesday the claims are preempted...To view the full article, register now.
Already a subscriber? Click here to view full article